Parcell Laboratories

About:

Parcell’s platform technology has the potential to deliver a diverse portfolio of products for multiple indications.

Website: http://www.parcelllabs.com/

Description:

Parcell Laboratories, founded in 2008, is focused on developing novel therapeutics around our unique adult stem cell platform technology, the ELA® cell. The ELA cell was discovered by scientists affiliated with the Brigham and Women’s Hospital and Harvard Medical School who demonstrated the vast potential of the technology in regenerative medicine. ELA cells are found in various tissues throughout the body and are characterized by a specific surface marker profile that set them apart from other adult stem cells.

Total Funding Amount:

$500000

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Natick, Massachusetts, United States

Founded Date:

2008-01-01

Founders:

Pamela Layton

Number of Employees:

1-10

Last Funding Date:

2014-05-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai